Q1 2019

Filed Apr 5, 2021 · 10-Q · 736 days after period end · 0001398432-21-000029

Q1 2019 · 10-Q

Revenue

$41.32K

+27.2% vs Q1 2018

Net Income

-$400.44K

N/M vs Q1 2018

EPS Diluted

$0.00

— vs Q1 2018

Gross Profit$25,697−3.5%

Operating Income

Same quarter

Metric	Q1 2019	Q1 2018	Q1 2017	Q1 2016
Revenue	$41.32K	$32.48K	$16.98K	$37.39K
Net Income	-$400.44K	-$4.09M	-$940.14K	-$1.07M
EPS Diluted	$0.00	$0.00	-$0.02	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR